Skip to main content
OpenTrials

Clinical trial condition

Metastatic Urothelial Carcinoma

Explore clinical trials studying Metastatic Urothelial Carcinoma. Study availability and eligibility vary by location and protocol.

53 public trials 18 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Urothelial Carcinoma trial results

Active, Not Recruiting

A Study of Efficacy and Safety of Pembrolizumab Plus Enfortumab Vedotin (EV) +/- Investigational Agents in First-Line Metastatic Urothelial Carcinoma (mUC) (MK-3475-04B/KEYMAKER-U04)

NCT05845814

Conditions
Carcinoma, Carcinoma, Transitional Cell, Metastatic Urothelial Carcinoma, +4 more
Locations
  • Moores Cancer Center ( Site 3028) La Jolla, California, United States
  • University of California, Irvine (UCI) Health - UC Irvine Medical Center ( Site 3045) Orange, California, United States
  • UCSF Medical Center at Mission Bay ( Site 3044) San Francisco, California, United States
  • Anschutz Cancer Pavilion ( Site 3017) Aurora, Colorado, United States
View all 47 locations
View Trial Details
Active, Not Recruiting

Eribulin Mesylate in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney Dysfunction

NCT00365157

Conditions
Advanced Urothelial Carcinoma, Carcinoma, Carcinoma, Transitional Cell, +9 more
Locations
  • Tower Cancer Research Foundation Beverly Hills, California, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • City of Hope Antelope Valley Lancaster, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 26 locations
View Trial Details

Related conditions